News & Updates
Inside Innovation
The latest news and advances from the world's most exciting life science cluster.
AGC Biologics Honored for Excellence in Development and Manufacturing
AGC Biologics received two awards from the annual CDMO Leadership Awards, sponsored by Outsourced Pharma and Life Science Connect. “We are honored that our customers
Science Firsthand: Predicting new possibilities in drug discovery
Predictive technologies are transforming R&D, accelerating the development of high-quality medicines, and bringing life-changing treatments to patients faster than ever before. In the latest episode
In buying cell therapy partner 2seventy bio for $286M, BMS takes full control of Abecma
Bristol Myers Squibb (BMS) has agreed to buy out 2seventy bio for a total equity value of about $286 million. The two companies had previously
Bothell medical tech company eyes local expansion after $28 million raise
After raising $28.3 million, Bothell-based VerAvanti is expanding its footprint in the Seattle region. Founded in 2013, VerAvanti specializes in imaging solutions and is developing
Seattle Hub for Synthetic Biology lands $10M to support ‘DNA Typewriter’ technology
The Seattle Hub for Synthetic Biology, a collaboration between the Allen Institute, the Chan Zuckerberg Initiative and the University of Washington, received a $10 million
Seattle biotech launches with $187 million for cancer treatments
Callio Therapeutics, which has dual headquarters in Seattle and Singapore, launched on Monday, March 3, with a $187 million Series A round. Specializing in cancer
Spokane startup that gives labs a green seal of approval raises $5M
Impact Laboratories, a Spokane-based startup verifying the environmental bona fides of approximately 3,800 labs worldwide, announced nearly $5 million in funding to expand its efforts.
Seed grant funding awarded to six collaborative projects
Washington State University Health Sciences and Seattle Children’s Research Institute awarded six collaborative projects $300,000 in seed grant funding, following an inaugural joint symposium between
Tasso rolls out new at-home dried blood spot sample collectors for remote clinical trials
Tasso, a Seattle-based maker of at-home blood sample collection systems, is launching the next generation of its devices that aim to support patients enrolled in
Selkirk Pharma introduces ClinFAST™ to expedite fill/finish for clinical trials
Selkirk Pharma, a contract manufacturing organization (CMO) based in Spokane, today announced the launch of ClinFAST™, a paradigm-shifting service designed to assist clinical stage biotech
Kestra Medical Technologies, maker of wearable cardiac devices, files for IPO
Kestra Medical Technologies, a Kirkland-based company selling cardiac monitoring and therapeutic devices, filed for an initial public offering on Monday. Kestra launched in 2014 and
BMS Positions Breyanzi for Another Indication as LOE Woes Mount
Bristol Myers Squibb (BMS) announced positive mid-stage results in marginal zone lymphoma for its CAR T cell therapy, Breyanzi, potentially leading to a new indication.